Home › Funds › Citadel Advisors › FDMT
Citadel Advisors position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q2 2026)901.20K sh
Reported value held$11.99M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 13.84K | $373.00K | New |
| Q4 2021 | 41.68K | $915.00K | Add |
| Q1 2022 | 125.83K | $1.90M | Add |
| Q2 2022 | 337.74K | $2.36M | Add |
| Q3 2022 | 211.86K | $1.70M | Reduce |
| Q4 2022 | 28.70K | $637.43K | Reduce |
| Q1 2023 | 23.17K | $398.33K | Reduce |
| Q2 2023 | 40.98K | $740.60K | Add |
| Q3 2023 | 153.42K | $1.95M | Add |
| Q4 2023 | 49.96K | $1.01M | Reduce |
| Q1 2024 | 166.03K | $5.29M | Add |
| Q2 2024 | 89.40K | $1.88M | Reduce |
| Q3 2024 | 200.15K | $2.16M | Add |
| Q4 2024 | 683.89K | $3.81M | Add |
| Q1 2025 | 389.91K | $1.26M | Reduce |
| Q2 2025 | 246.04K | $912.80K | Reduce |
| Q3 2025 | 35.80K | $311.10K | Reduce |
| Q4 2025 | 70.89K | $531.67K | Add |
| Q1 2026 | 317.10K | $2.95M | Add |
| Q2 2026 | 901.20K | $11.99M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026